Medicine regulation – News, Research and Analysis – The Conversation

Articles on Medicine regulation

December 3, 2020

Should Australians be worried about waiting for a COVID vaccine when the UK has just approved Pfizer’s?

Joel Lexchin, University of Toronto; Barbara Mintzes, University of Sydney; Kellia Chiu, University of Sydney, and Lisa Parker, University of Sydney

Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?

May 13, 2020

Parastou Donyai, University of Reading; Rachel McCrindle, University of Reading; Robert Simon Sherratt, University of Reading, and Terence Hui, University of Reading

The UK government is allowing care homes and hospices to reuse leftover medicines during the pandemic. Here’s why that’s a good thing.

June 6, 2018

Harry Sumnall, Liverpool John Moores University

Medical cannabis challenges scientific norms and the usual regulation of medicines.

Lisa Parker
Honorary Lecturer, School of Pharmacy, Charles Perkins Centre, University of Sydney
Barbara Mintzes
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
Harry Sumnall
Professor in Substance Use, Liverpool John Moores University
Joel Lexchin
Joel Lexchin is a Friend of The Conversation.

Professor Emeritus of Health Policy and Management, York University, Canada
Terence Hui
Postdoctoral research associate, University of Reading
Rachel McCrindle
Professor of Computer and Human Interaction, University of Reading
Robert Simon Sherratt
Professor of Biosensors, University of Reading
Kellia Chiu
PhD Candidate and Pharmacist, University of Sydney
Parastou Donyai
Head of the Department of Pharmacy, King's College London